News & Latest Announcements
Significant milestone in the golexanolone Phase 2 study!
We are happy to announce that the first two patients have been successfully randomized in the Phase 2 portion of the clinical trial evaluating golexanolone for…
Read article
Accelsiors at Bio Korea 2024
We’re still under the impact of Bio Korea 2024. This prestigious event brought together leading minds and organizations in biotechnology from around the world to discuss…
Read article
Swiss Biotech Day 2024: Exploring the Biotech Landscape
Accelsiors is pleased to present the key highlights of our participation in the highly anticipated Swiss Biotech Day 2024, which took place on April 22-23 at…
Read article
Accelsiors at Pharmabiotics Conference 2024
We are thrilled about our participation at the Pharmabiotics Conference & Partnering 2024. The event took place in Lille, France, marking the 9th edition of this…
Read article
ADPD 2024: A Global Gathering of Neurology Experts
Accelsiors continues to support ADPD, with our attendance at this year’s conference in Lisbon, in March 2024! ADPD 2024, brought together esteemed colleagues, investigators, and partners…
Read article
Accelsiors Webinar: Running Clinical Trials in Europe
On March 14th, 2024 at 18:00 CET, Accelsiors is hosting an exclusive webinar on Key Regulatory & Legal Requirements for Running Clinical Trials in Europe. This…
Read article
Navigating the New Swiss Privacy Regime: Implications for Clinical Trials
The revised Swiss Federal Act on Data Protection (FADP) went into effectiveness September 1, 2023, and it poses significant challenges for clinical trials. The new law…
Read article
Accelsiors at ESMO Congress 2023
ESMO 2023 brings together researchers, clinicians, scientists and healthcare market leaders from all over the world. The congress hosts the latest cutting-edge data, high-quality education, and…
Read article
Our New US Office!
We are marking an exciting, new milestone with the opening of Accelsiors’ Los Angeles office – a significant step in our journey to bring our services…
Read article